CytoMed Therapeutics GDTC
NASDAQ GDTC
$0.92 +0.02 (+2.22%)
At close: Oct 22, 2026 · 4:00 PM EDT

CytoMed Therapeutics (GDTC) Other Non Operating Income (2024 - 2025)

Updated

CytoMed Therapeutics' Other Non Operating Income came in at $132,030 for FY2025, down 19.3% from $163,645 in FY2024.

Analysis

CytoMed Therapeutics (GDTC) Other Non Operating Income (2024 - 2025) Analysis & Trends

Going back to FY2020, CytoMed Therapeutics' Other Non Operating Income data covers 6 years.

  • The five-year range for annual Other Non Operating Income is -$96,504 (FY2022) to $163,645 (FY2024).
  • Per Business Quant, earlier years put Other Non Operating Income at $163,645 in FY2024 (+45.8%), $112,214 in FY2023, -$96,504 in FY2022 and -$22,628 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 CytoMed Therapeutics 10.60 Mn 996,480.66 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 190,932.00
Jun 30, 2024 -210,633.00
API Access

CytoMed Therapeutics Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=GDTC&period=max&api_key=YOUR_API_KEY